- In November 2024, Nestlé Health Science launched a new range of Garden of Life probiotics in the U.K. and Ireland, marking a major expansion of its natural supplement portfolio. For the first time, these microbiome supplements became available in over 600 Holland & Barrett stores and online, significantly boosting the brand’s visibility in the region. The range includes high-potency, one-capsule-a-day formulas tailored for men, women, prenatal care, and mood support, with up to 50 billion CFU and 15 live bacteria strains per serving. This move reinforces Nestlé’s commitment to natural, science-backed wellness solutions in the European market
- In April 2024, Nutriearth, a specialist in natural vitamin D3, launched two innovative products at Vitafoods Europe 2025: N-utra, a vitamin D3-rich mealworm flour, and N-oil, a highly bioavailable vitamin D3 oil. N-utra received novel food approval from the European Commission in early 2025, marking a significant milestone for insect-based nutrition. Both products are designed to meet rising demand for sustainable, natural vitamin sources. To support this growth, Nutriearth expanded its production capacity by establishing two new cleanrooms in Lille, France, enabling large-scale output while maintaining pharmaceutical-grade hygiene standards
- In September 2023, Cosmos Holdings, Inc., operating as Cosmos Health, entered into an exclusive distribution agreement with Mediprovita GbR to bring its Sky Premium Life nutraceuticals to the German market. This partnership marked a strategic expansion of Cosmos Health’s European footprint, targeting the region’s growing demand for natural vitamins and supplements. Mediprovita, with over 30 years of experience in consumer product logistics and e-commerce, began distributing an initial 20 SKUs via Amazon, eBay, and its own platform, with plans to scale up to 70 SKUs. The collaboration leverages Mediprovita’s strong market presence to reach health-conscious consumers across Germany and Austria
- In July 2023, STADA Arzneimittel AG significantly expanded its European Consumer Healthcare portfolio by acquiring a range of well-established brands from Sanofi across countries including Belgium, Germany, Hungary, Spain, the UK, and the Nordic region. The acquisition included products such as Antistax, Lomudal, Omnivit, and Opticrom, strengthening STADA’s presence in the natural vitamins, supplements, and allergy care segments. This move supports STADA’s strategy to become a top-four player in Europe’s consumer healthcare market, leveraging its extensive sales and distribution network to grow these trusted brands
- In November 2022, Royal DSM completed its acquisition of AVA, a Boston-based personalized nutrition platform that leverages AI-driven analytics to deliver tailored nutrition and coaching recommendations across diverse health and wellness segments. This move reinforced DSM’s strategy to lead in personalized nutrition, combining AVA’s digital capabilities with DSM’s science-backed nutritional products. The acquisition supports DSM’s expansion in the European natural vitamins and supplements market, aligning with rising consumer demand for data-driven, individualized health solutions
